{"id":20897,"date":"2016-08-23T12:02:08","date_gmt":"2016-08-23T10:02:08","guid":{"rendered":"http:\/\/www.w-t-w.org\/de\/?p=20897"},"modified":"2016-08-23T12:05:51","modified_gmt":"2016-08-23T10:05:51","slug":"krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie","status":"publish","type":"post","link":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/","title":{"rendered":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie?"},"content":{"rendered":"<p>Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten. Pfizer zahlt 14 Milliarden Dollar f\u00fcr Krebsspezialisten und hat damit das Bieterrennen um Medivation gewonnen.<\/p>\n<h4>Mindestens f\u00fcnf Konzerne hatten ihr Interesse an einem Deal angemeldet. Der Konzern unterstreicht damit seine ge\u00e4nderte Akquisitionsstrategie nach dem Scheitern der Fusion mit dem Botox-Hersteller Allergan im Wert von 160 Milliarden Dollar. Ging es dabei noch vor allem um eine Reduzierung der Steuerlast, steht nun die St\u00e4rkung des Medikamenten-Portfolios ganz oben. Medivation stellt das Prostatakrebs-Medikament Xtandi her, von dem Analysten erwarten, dass es bis 2020 allein 1,33 Milliarden Dollar (1,28 Milliarden Schweizer Franken) erl\u00f6sen wird.<\/h4>\n<p>An der B\u00f6rse schoss die Medivation-Aktie kurz nach Handelsbeginn 20 Prozent in die H\u00f6he auf 80,50 Dollar und lag damit wenig unter dem von Pfizer gebotenen Bar-Kaufpreis von 81,50 Dollar je Papier.<br \/>\n<a href=\"http:\/\/www.w-t-w.org\/de\/wieviel-geld-hat-mein-arzt-von-pharmafirmen-erhalten\/\" target=\"_blank\">Wieviel Geld hat mein Arzt von Pharmafirmen erhalten<\/a><br \/>\n<a href=\"http:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/pharma\/\" target=\"_blank\" rel=\"attachment wp-att-20898\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-20898\" src=\"http:\/\/www.w-t-w.org\/de\/wp-content\/uploads\/2016\/08\/Pharma.jpg\" alt=\"Pharma\" width=\"380\" height=\"300\" srcset=\"https:\/\/www.w-t-w.org\/de\/wp-content\/uploads\/2016\/08\/Pharma.jpg 380w, https:\/\/www.w-t-w.org\/de\/wp-content\/uploads\/2016\/08\/Pharma-300x237.jpg 300w\" sizes=\"auto, (max-width: 380px) 100vw, 380px\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten. Pfizer zahlt 14 Milliarden Dollar f\u00fcr Krebsspezialisten und hat damit das Bieterrennen um Medivation gewonnen. Mindestens f\u00fcnf Konzerne hatten &hellip; <a href=\"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/\">Weiterlesen <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"give_campaign_id":0,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-20897","post","type-post","status-publish","format-standard","hentry","category-finanzen"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Thora Gr\u00edms\"\/>\n\t<meta name=\"keywords\" content=\"women,frauen,finance,finanzen,europa,krebs,daten,pharmaindustrie,chemotherapie,apotheker\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"de_DE\" \/>\n\t\t<meta property=\"og:site_name\" content=\"W-T-W.org | Women and Finance\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | W-T-W.org\" \/>\n\t\t<meta property=\"og:description\" content=\"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2016-08-23T10:02:08+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2016-08-23T10:05:51+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | W-T-W.org\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#article\",\"name\":\"Krebs ein gutes Gesch\\u00e4ft f\\u00fcr die Pharmaindustrie | W-T-W.org\",\"headline\":\"Krebs ein gutes Gesch\\u00e4ft f\\u00fcr die Pharmaindustrie?\",\"author\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/author\\\/thora-grims\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/Pharma.jpg\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#articleImage\",\"width\":380,\"height\":300},\"datePublished\":\"2016-08-23T12:02:08+02:00\",\"dateModified\":\"2016-08-23T12:05:51+02:00\",\"inLanguage\":\"de-DE\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#webpage\"},\"articleSection\":\"Finanzen\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.w-t-w.org\\\/de\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/category\\\/finanzen\\\/#listItem\",\"name\":\"Finanzen\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/category\\\/finanzen\\\/#listItem\",\"position\":2,\"name\":\"Finanzen\",\"item\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/category\\\/finanzen\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#listItem\",\"name\":\"Krebs ein gutes Gesch\\u00e4ft f\\u00fcr die Pharmaindustrie?\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#listItem\",\"position\":3,\"name\":\"Krebs ein gutes Gesch\\u00e4ft f\\u00fcr die Pharmaindustrie?\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/category\\\/finanzen\\\/#listItem\",\"name\":\"Finanzen\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/#organization\",\"name\":\"W-T-W.org\",\"description\":\"Women and Finance\",\"url\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/author\\\/thora-grims\\\/#author\",\"url\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/author\\\/thora-grims\\\/\",\"name\":\"Thora Gr\\u00edms\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2ed2258ebc444ebd985f92509fea4f9954b5cba01bcaab47af90b5ea2fc8fc75?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Thora Gr\\u00edms\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#webpage\",\"url\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/\",\"name\":\"Krebs ein gutes Gesch\\u00e4ft f\\u00fcr die Pharmaindustrie | W-T-W.org\",\"description\":\"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten\",\"inLanguage\":\"de-DE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/author\\\/thora-grims\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/author\\\/thora-grims\\\/#author\"},\"datePublished\":\"2016-08-23T12:02:08+02:00\",\"dateModified\":\"2016-08-23T12:05:51+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/\",\"name\":\"W-T-W.org\",\"description\":\"Women and Finance\",\"inLanguage\":\"de-DE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.w-t-w.org\\\/de\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | W-T-W.org","description":"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten","canonical_url":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/","robots":"max-image-preview:large","keywords":"women,frauen,finance,finanzen,europa,krebs,daten,pharmaindustrie,chemotherapie,apotheker","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#article","name":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | W-T-W.org","headline":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie?","author":{"@id":"https:\/\/www.w-t-w.org\/de\/author\/thora-grims\/#author"},"publisher":{"@id":"https:\/\/www.w-t-w.org\/de\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.w-t-w.org\/de\/wp-content\/uploads\/2016\/08\/Pharma.jpg","@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#articleImage","width":380,"height":300},"datePublished":"2016-08-23T12:02:08+02:00","dateModified":"2016-08-23T12:05:51+02:00","inLanguage":"de-DE","mainEntityOfPage":{"@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#webpage"},"isPartOf":{"@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#webpage"},"articleSection":"Finanzen"},{"@type":"BreadcrumbList","@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.w-t-w.org\/de#listItem","position":1,"name":"Home","item":"https:\/\/www.w-t-w.org\/de","nextItem":{"@type":"ListItem","@id":"https:\/\/www.w-t-w.org\/de\/category\/finanzen\/#listItem","name":"Finanzen"}},{"@type":"ListItem","@id":"https:\/\/www.w-t-w.org\/de\/category\/finanzen\/#listItem","position":2,"name":"Finanzen","item":"https:\/\/www.w-t-w.org\/de\/category\/finanzen\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#listItem","name":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie?"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.w-t-w.org\/de#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#listItem","position":3,"name":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie?","previousItem":{"@type":"ListItem","@id":"https:\/\/www.w-t-w.org\/de\/category\/finanzen\/#listItem","name":"Finanzen"}}]},{"@type":"Organization","@id":"https:\/\/www.w-t-w.org\/de\/#organization","name":"W-T-W.org","description":"Women and Finance","url":"https:\/\/www.w-t-w.org\/de\/"},{"@type":"Person","@id":"https:\/\/www.w-t-w.org\/de\/author\/thora-grims\/#author","url":"https:\/\/www.w-t-w.org\/de\/author\/thora-grims\/","name":"Thora Gr\u00edms","image":{"@type":"ImageObject","@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/2ed2258ebc444ebd985f92509fea4f9954b5cba01bcaab47af90b5ea2fc8fc75?s=96&d=mm&r=g","width":96,"height":96,"caption":"Thora Gr\u00edms"}},{"@type":"WebPage","@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#webpage","url":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/","name":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | W-T-W.org","description":"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten","inLanguage":"de-DE","isPartOf":{"@id":"https:\/\/www.w-t-w.org\/de\/#website"},"breadcrumb":{"@id":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/#breadcrumblist"},"author":{"@id":"https:\/\/www.w-t-w.org\/de\/author\/thora-grims\/#author"},"creator":{"@id":"https:\/\/www.w-t-w.org\/de\/author\/thora-grims\/#author"},"datePublished":"2016-08-23T12:02:08+02:00","dateModified":"2016-08-23T12:05:51+02:00"},{"@type":"WebSite","@id":"https:\/\/www.w-t-w.org\/de\/#website","url":"https:\/\/www.w-t-w.org\/de\/","name":"W-T-W.org","description":"Women and Finance","inLanguage":"de-DE","publisher":{"@id":"https:\/\/www.w-t-w.org\/de\/#organization"}}]},"og:locale":"de_DE","og:site_name":"W-T-W.org | Women and Finance","og:type":"article","og:title":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | W-T-W.org","og:description":"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten","og:url":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/","article:published_time":"2016-08-23T10:02:08+00:00","article:modified_time":"2016-08-23T10:05:51+00:00","twitter:card":"summary","twitter:title":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | W-T-W.org","twitter:description":"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten"},"aioseo_meta_data":{"post_id":"20897","title":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie | #site_title","description":"Der US-Pharmariese Pfizer hat den milliardenschweren Bieterwettstreit um den US-Krebsspezialisten Medivation f\u00fcr sich entschieden.Der US-Pharmariese will sein Portfolio von Krebsmedikamenten ausweiten","keywords":[{"label":"Women","value":"Women"},{"label":"Frauen","value":"Frauen"},{"label":"Finance","value":"Finance"},{"label":"Finanzen","value":"Finanzen"},{"label":"Europa","value":"Europa"},{"label":"Krebs","value":"Krebs"},{"label":"Daten","value":"Daten"},{"label":"Pharmaindustrie","value":"Pharmaindustrie"},{"label":"Chemotherapie","value":"Chemotherapie"},{"label":"Apotheker","value":"Apotheker"}],"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"schema_type":null,"schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"location":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2020-12-21 13:21:30","updated":"2025-07-14 09:34:13","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.w-t-w.org\/de\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.w-t-w.org\/de\/category\/finanzen\/\" title=\"Finanzen\">Finanzen<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tKrebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie?\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.w-t-w.org\/de"},{"label":"Finanzen","link":"https:\/\/www.w-t-w.org\/de\/category\/finanzen\/"},{"label":"Krebs ein gutes Gesch\u00e4ft f\u00fcr die Pharmaindustrie?","link":"https:\/\/www.w-t-w.org\/de\/krebs-ein-gutes-geschaeft-fuer-die-pharmaindustrie\/"}],"_links":{"self":[{"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/posts\/20897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/comments?post=20897"}],"version-history":[{"count":4,"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/posts\/20897\/revisions"}],"predecessor-version":[{"id":20902,"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/posts\/20897\/revisions\/20902"}],"wp:attachment":[{"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/media?parent=20897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/categories?post=20897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.w-t-w.org\/de\/wp-json\/wp\/v2\/tags?post=20897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}